CompletedNot Applicable

Norepinephrine Prophylaxis for Postspinal Anesthesia Hypotension in Parturients With Preeclampsia.

China180 participantsStarted 2021-11-16

Plain-language summary

The purpose of this study is to investigate the suitable infusion dose of norepinephrine for prophylaxis against postspinal anesthesia hypotension in parturients with preeclampsia undergoing cesarean section.

Who can participate

Age range18 Years – 45 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * 18-45 years * Primipara or multipara * Singleton pregnancy ≥32 weeks * American Society of Anesthesiologists physical status classification II to III * Scheduled for cesarean section under spinal anesthesia Exclusion Criteria: * Baseline blood pressure ≥180 mmHg * Body height \< 150 cm * Body weight \> 100 kg or body mass index (BMI) ≥ 40 kg/m2 * Eclampsia or chronic hypertension * Hemoglobin \< 7g/dl * Fetal distress, or known fetal developmental anomaly

What they're measuring

The incidence of post-spinal anesthesia hypotension

Timeframe: 1-15 minutes after spinal anesthesia.

Trial details

NCT IDNCT04556370

SponsorGeneral Hospital of Ningxia Medical University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-06-06

View on ClinicalTrials.gov More Adverse Effect trials